| Literature DB >> 23118792 |
Mu-Lien Lin1, Hung-Chien Wu, Ya-Hui Hsieh, Chuan-Tsung Su, Yong-Sheng Shih, Chii-Wann Lin, Jih-Huah Wu.
Abstract
The purpose of this study was to evaluate the effect of laser acupuncture (LA) and soft cupping on low back pain. In this study, the subjects were randomly assigned to two groups: active group (real LA and soft cupping) and placebo group (sham laser and soft cupping). Visual analog scale (VAS) and Ryodoraku were used to evaluate the effect of treatment on low back pain in this trial. Laser, 40 mW, wavelength 808 nm, pulse rate 20 Hz, was used to irradiate Weizhong (BL40) and Ashi acupoints for 10 minutes. And the Ryodoraku values were measured 2 times, that is, before and 15 minutes after treatment. The results show that there were significant difference between the first day baseline and the fifth day treatment in VAS in the two groups. Therefore, LA combined with soft cupping or only soft cupping was effective on low back pain. However, the Ryodoraku values of Bladder Meridian of the placebo group have been decreased apparently, and didn't come back to their original values. It means that "cupping" plays the role of "leak or purge" in traditional Chinese medicine (TCM). On the other hand, the Ryodoraku values of Bladder Meridian of the active group have been turned back to almost their original values; "mend or reinforcing" effect is attributed to the laser radiation.Entities:
Year: 2012 PMID: 23118792 PMCID: PMC3482015 DOI: 10.1155/2012/521612
Source DB: PubMed Journal: Evid Based Complement Alternat Med ISSN: 1741-427X Impact factor: 2.629
Figure 1Protocol in this study.
Figure 2Weizhong (BL40) acupoint.
Figure 3The treatment combining LA with soft cupping in this study.
Figure 4Consort flow diagram.
Demographic data for the study groups.
| Age | Weight (Kg) | Height (cm) | BMI (kg/m2) | |
|---|---|---|---|---|
| Active ( | 63.35 ± 11.23 | 69.04 ± 12.17 | 160.00 ± 8.74 | 26.98 ± 4.33 |
| Control ( | 64.65 ± 13.57 | 64.41 ± 15.50 | 159.68 ± 9.26 | 25.07 ± 4.24 |
Comparisons between the Ryodoraku values of 12 meridians at baseline and that after therapy from the first day to the fifth day in two groups.
| 12 meridians | Active | Placebo | Active group | Placebo group | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Baseline | Combine LA with soft cupping | Soft cupping | ||||||||||
| First day | First day | First day | Second day | Third day | Fourth day | Fifth day | First day | Second day | Third day | Fourth day | Fifth day | |
| Before | After | After | ||||||||||
| Lung | 47.55 ± 19.71 | 46.54 ± 18.71 | 35.25 ± 20.73∗ | 37.13 ± 21.69 | 45.80 ± 26.33 | 35.74 ± 17.30 | 52.81 ± 24.37 | 40.24 ± 23.04 | 32.40 ± 19.65∗ | 34.23 ± 19.81∗ | 31.39 ± 18.71∗∗ | 38.08 ± 2.86 |
| Pericardium | 43.47 ± 16.19 | 40.12 ± 17.22 | 34.42 ± 19.83 | 33.59 ± 20.38 | 41.24 ± 25.18 | 33.41 ± 19.55 | 42.48 ± 20.02 | 36.12 ± 19.65 | 29.31 ± 17.01∗ | 30.34 ± 17.29∗ | 29.58 ± 18.21∗∗ | 33.50 ± 22.23 |
| Heart | 37.84 ± 13.51 | 35.96 ± 15.81 | 28.16 ± 16.19∗ | 27.35 ± 16.14∗ | 34.22 ± 16.54 | 28.30 ± 13.55∗ | 35.44 ± 15.58 | 31.33 ± 16.93 | 24.92 ± 15.76∗ | 25.76 ± 16.28∗ | 24.74 ± 15.55∗∗ | 29.73 ± 21.37 |
| Small intestine | 45.84 ± 16.61 | 41.74 ± 18.14 | 34.85 ± 20.43∗ | 34.47 ± 21.38∗ | 40.13 ± 22.14 | 35.46 ± 17.94 | 45.36 ± 21.79 | 37.11 ± 19.86 | 28.45 ± 17.30∗ | 30.14 ± 17.79∗ | 29.48 ± 19.86∗∗ | 34.04 ± 21.93 |
| Triple energizer | 47.54 ± 22.36 | 45.08 ± 19.83 | 39.89 ± 23.45 | 40.08 ± 22.95 | 47.04 ± 26.78 | 39.27 ± 18.25 | 52.90 ± 27.02 | 38.18 ± 22.25 | 31.31 ± 18.96∗ | 34.72 ± 18.94∗ | 29.56 ± 18.36∗ | 37.12 ± 20.08 |
| Large intestine | 46.33 ± 20.28 | 46.48 ± 19.65 | 29.23 ± 21.28 | 38.34 ± 20.22 | 47.17 ± 26.00 | 36.17 ± 14.98 | 50.29 ± 21.21 | 37.82 ± 22.04 | 30.60 ± 18.93 ∗∗ | 34.71 ± 17.20∗ | 31.77 ± 18.67∗∗ | 35.24 ± 18.39∗ |
| Spleen | 36.86 ± 13.3 | 38.42 ± 23.62 | 28.02 ± 19.37∗∗ | 30.76 ± 20.70 | 35.94 ± 24.89 | 29.53 ± 15.82 | 34.73 ± 19.97 | 29.17 ± 13.47 | 24.67 ± 15.31 | 22.03 ± 12.40∗∗ | 24.12 ± 15.40∗ | 24.65 ± 13.55∗ |
| Liver | 34.96 ± 15.12 | 33.96 ± 17.06 | 24.58 ± 18.91∗∗ | 25.66 ± 18.49∗∗ | 36.71 ± 24.23 | 26.55 ± 14.50 | 34.81 ± 20.47 | 29.06 ± 16.78 | 24.25 ± 14.85∗ | 25.64 ± 16.01∗ | 22.03 ± 15.64∗∗ | 25.76 ± 15.85∗ |
| Kidney | 25.05 ± 13.27 | 30.23 ± 15.88 | 22.52 ± 18.19 | 25.04 ± 18.77 | 28.65 ± 20.06 | 24.19 ± 15.74 | 28.51 ± 16.36 | 28.58 ± 15.32 | 19.40 ± 13.58∗ | 21.24 ± 13.87∗ | 20.46 ± 13.40∗∗ | 25.03 ± 16.22 |
| Bladder | 31.93 ± 12.37 | 32.93 ± 19.79 | 23.36 ± 16.94∗∗ | 24.32 ± 17.66∗∗ | 30.34 ± 20.63 | 25.76 ± 15.36∗ | 28.08 ± 13.87 | 25.09 ± 12.50 | 22.43 ± 13.50 | 19.84 ± 12.48∗ | 20.51 ± 12.52∗ | 20.91 ± 12.05∗ |
| Gallbladder | 25.49 ± 12.59 | 27.66 ± 15.55 | 21.10 ± 17.01 | 22.75 ± 17.33 | 28.31 ± 19.03 | 23.90 ± 13.04 | 28.51 ± 17.49 | 25.62 ± 15.65 | 18.82 ± 12.11∗ | 22.04 ± 14.84 | 19.74 ± 14.02∗ | 21.78 ± 11.85 |
| Stomach | 31.27 ± 13.08 | 30.94 ± 16.74 | 21.10 ± 17.01 | 25.76 ± 18.59 | 33.02 ± 20.83 | 26.85 ± 16.13 | 29.15 ± 18.75 | 25.70 ± 14.03 | 21.23 ± 12.39∗ | 23.63 ± 15.71∗ | 21.90 ± 13.76∗ | 21.72 ± 14.08∗ |
∗ P < 0.05 by paired-samples t-test.
∗∗ P < 0.01 by paired-samples t-test.
Data are expressed as means ± standard deviation.
Figure 5The change of Ryodoraku value of Bladder Meridian after treatment in two groups.
Figure 6Statistics and analysis VAS of patients after the treatment in two groups.
Comparison of the two groups in VAS in each treatment.
| Active group | Placebo group |
| |
|---|---|---|---|
| First day | 5.00 ± 1.96 | 5.46 ± 1.96 | 0.214 |
| Second day | 4.60 ± 2.11 | 5.09 ± 2.12 | 0.182 |
| Third day | 4.03 ± 2.03 | 4.49 ± 1.96 | 0.126 |
| Forth day | 3.60 ± 1.58 | 3.85 ± 1.97 | 0.088 |
| Fifth day | 3.11 ± 1.54 | 3.20 ± 1.84 | 0.145 |
∗∗ P < 0.01 by paired-samples t-test.
VAS comparison of active group.
| Active group |
| ||
|---|---|---|---|
| First day | Fifth day | ||
| Before | 6.25 ± 1.75 | 4.25 ± 1.72 | 0.000∗∗ |
| After | 5.00 ± 1.96 | 3.11 ± 1.54 | 0.000∗∗ |
∗∗ P < 0.01 by paired-samples t-test.
VAS comparison of placebo group.
| Placebo group |
| ||
|---|---|---|---|
| First day | Fifth day | ||
| Before | 6.54 ± 2.05 | 3.72 ± 1.67 | 0.000∗∗ |
| After | 5.46 ± 1.96 | 3.20 ± 1.84 | 0.000∗∗ |
∗∗ P < 0.01 by paired-samples t-test.